ImmunoPrecise Enters Agreement to Develop Immune-Contraceptive Vaccines for Wildlife Pharmaceutical Investing
DelMar Pharmaceuticals Receives Approval from China's Human Genetic Resources Administration to Initiate Phase 2 Clinical Trial in Newly Diagnosed GBM Pharmaceutical Investing